Salarius Pharmaceuticals Inc (NASDAQ:SLRX) does about 1.95M shares in volume on a normal day but saw 1271212 shares change hands in the recent trading day. The company now has a market cap of 1.91M USD. Its current market price is $3.19, marking a decrease of -8.86% compared to the previous close of $3.50. The 52 week high reached by this stock is $7.92 whilst the lowest price level in 52 weeks is $1.35.
Salarius Pharmaceuticals Inc (SLRX) has a 20-day trading average at $2.28 and the current price is -59.72% off the 52-week high compared with 136.30% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.97 and its 200-day simple moving average is $4.41. If we look at the stock’s price movements over the week, volatility stands at 106.39%, which decreases to 43.70% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.52 to suggest the stock is neutral.
The consensus objective for the share price is $26.00, suggesting that the stock has a potential upside of 87.73% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 27, 2020 when Ladenburg Thalmann initiated the stock to “Buy” and issued a price target of $3.80.
Salarius Pharmaceuticals Inc (SLRX) stock is up 74.32% over the week and 28.63% over the past month. Its price is -38.65% year-to-date and -53.20% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -17.84 above consensus estimates by 2.16. The company’s next earnings report forecasts estimating quarterly EPS at -53.6 and -214.4 for whole year.
To reach the target analysts have set, the stock logically needs to grow 87.73 percent from here.
The company has a return on investment of -244.34% and return on equity of -193.68%. The beta has a value of 0.85. Price to book ratio is 0.47.
